Citadel Advisors’s VolitionRx VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.3K Buy
+47,656
New +$32.2K ﹤0.01% 13759
2026
Q1
– Sell
-8,387
Closed -$42.9K – 14329
2025
Q4
$42.9K Sell
8,387
-8,089
-49% -$61.4K ﹤0.01% 12106
2025
Q3
$224K Buy
16,476
+6,789
+70% +$90.4K ﹤0.01% 11027
2025
Q2
$147K Buy
+9,687
New +$107K ﹤0.01% 10974
2025
Q1
– Sell
-3,410
Closed -$40.9K – 15646
2024
Q4
$40.9K Buy
+3,410
New +$45.8K ﹤0.01% 12602
2024
Q3
– Sell
-1
Closed -$13 – 15339
2024
Q2
$18 Buy
+1
New +$15 ﹤0.01% 14122
2023
Q3
– Sell
-316
Closed -$8.78K – 15199
2023
Q2
$8.78K Sell
316
-700
-69% -$23K ﹤0.01% 13296
2023
Q1
$38.8K Sell
1,016
-3,082
-75% -$129K ﹤0.01% 12463
2022
Q4
$199K Sell
4,098
-1,096
-21% -$42.6K ﹤0.01% 10149
2022
Q3
$141K Buy
5,194
+3,910
+305% +$148K ﹤0.01% 10778
2022
Q2
$53K Sell
1,284
-23
-2% -$1.16K ﹤0.01% 11900
2022
Q1
$79K Buy
1,307
+760
+139% +$43.1K ﹤0.01% 12485
2021
Q4
$34K Sell
547
-407
-43% -$27.8K ﹤0.01% 13426
2021
Q3
$59K Buy
+954
New +$60.4K ﹤0.01% 13276
2020
Q3
– Sell
-644
Closed -$50K – 10794
2020
Q2
$50K Buy
+644
New +$46.5K ﹤0.01% 9307

Other funds holding VNRX

Citadel Advisors's VNRX Position: Q3 2026 in Review

Citadel Advisors opened a new position in VolitionRx (VNRX) in Q3 2026: 47,656 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #13759 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in VNRX as recently as Q4 2025.

Citadel Advisors first reported a position in VNRX in Q2 2020 and has held it in 15 quarters since. The position peaked at $224K in Q3 2025. 28 funds tracked by Wall St. Rank hold VNRX as of Q3 2026.

  • Citadel Advisors held 47,656 shares of VolitionRx worth $12.3K as of Q3 2026.
  • VolitionRx was a new Citadel Advisors position in Q3 2026.
  • VolitionRx made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13759 holding.
  • Citadel Advisors first reported a position in VolitionRx in Q2 2020 and has held it in 15 quarters since.
  • Citadel Advisors's VolitionRx position peaked at $224K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held VolitionRx as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.